Buyback yield (TTM)
N/A
Shareholder yield (TTM)
N/A
5Y share count change
16.3%
Buyback spend (TTM)
N/A
Cumulative buybacks
$619.00K
Key takeaways
- Diluted share count is up 16.3% over the last ~5 fiscal years — equity issuance and stock-based compensation are outpacing repurchases.
- Cash buyback spend has compounded at -100.0% per year over the latest 5-year window.
Dividend & buyback yield over time for Kodiak Sciences (KOD)
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Diluted vs basic shares (annual) for Kodiak Sciences (KOD)
Diluted weighted-average shares are the EPS denominator — a falling count means buybacks are outpacing SBC dilution.
Year-over-year change in diluted shares for Kodiak Sciences (KOD)
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Cash buyback spend over time for Kodiak Sciences (KOD)
Latest: $0.00
Overview
In 2025, Kodiak Sciences (KOD) buyback spend totalled $0.00.
Through 2020–2025 (5 years), Kodiak Sciences buyback spend delivered a -100.0% annualised rate; with a net decline across the window.
Kodiak Sciences buyback spend peaked at $487.00K in 2020; the latest annual figure is $0.00 in 2025 (100.0% below peak).
The record annual buyback spend stands at $487.00K, reached in 2020; the historical low of $0.00 was recorded in 2016.
Kodiak Sciences Buyback Spend 2025: $0.00
Kodiak Sciences buyback spend in 2025 was $0.00.
Kodiak Sciences Buyback Spend 2024: $0.00
Kodiak Sciences buyback spend in 2024 was $0.00.
Kodiak Sciences Buyback Spend 2023: $0.00
Kodiak Sciences buyback spend in 2023 was $0.00.
Kodiak Sciences Buyback Spend 2022: $0.00
Kodiak Sciences buyback spend in 2022 was $0.00.
Kodiak Sciences Buyback Spend 2021: $0.00
Kodiak Sciences buyback spend in 2021 was $0.00.
See more financial history for Kodiak Sciences (KOD).
Buyback, SBC & dilution history
Buyback spend, SBC, net dilution effect, and share count.
| 2025 | $0.00 | $58.86M | −$58.86M | — | 0.05B | +1.2% | |
| 2024 | $0.00 | $60.21M | −$60.21M | — | 0.05B | +0.3% | |
| 2023 | $0.00 | $88.56M | −$88.56M | — | 0.05B | +0.3% | |
| 2022 | $0.00 | $106.03M | −$106.03M | — | 0.05B | +0.9% | |
| 2021 | $0.00 | $61.38M | −$61.38M | — | 0.05B | +13.2% | |
| 2020 | $487.00K | $30.67M | −$30.18M | 0.03% | 0.05B | +20.8% | |
| 2019 | $132.00K | $6.11M | −$5.98M | 0.02% | 0.04B | +5.5% | |
| 2018 | $0.00 | $2.67M | −$2.67M | — | 0.04B | +35.1% | |
| 2017 | $0.00 | $275.00K | −$275.00K | — | 0.03B | +256.7% | |
| 2016 | $0.00 | $272.00K | −$272.00K | — | 0.01B | — |
- 2025$0.00
- 2024$0.00
- 2023$0.00
- 2022$0.00
- 2021$0.00
- 2020$487.00K
- 2019$132.00K
- 2018$0.00
- 2017$0.00
- 2016$0.00
Buybacks vs stock-based compensation for Kodiak Sciences (KOD)
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 0.00×.
Buybacks vs dividends (share of cash returned) for Kodiak Sciences (KOD)
How Kodiak Sciences splits cash returned to shareholders between dividends and buybacks.
Sector peers by buyback spend
Companies in the same sector as Kodiak Sciences, ranked by their latest buyback spend.
| $5.95B | |
| $5.54B | |
| $5.08B | |
| $4.11B | |
| $980.00M | |
| $719.66M | |
| $216.35M | |
| $0.00 |
- $5.95B
- $5.54B
- $5.08B
- $4.11B
- $980.00M
- $719.66M
- $216.35M
- $0.00
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $0.00 (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Data & methodology
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation